New research offers 'critical insights' for treating, preventing Alzheimer's disease

September 16, 2016 by Thea Singer
New research offers ‘critical insights’ for treating, preventing Alzheimer’s disease
Northeastern professor Lee Makowski and his colleagues suggest that Alzheimer’s disease may progress not like falling dominoes, with one molecular event sparking the formation of plaques throughout the brain, but rather like a fireworks display, with a unique flare launching each plaque, one by one. The finding provides “critical insights for developing therapies to slow, halt, or reverse” the disease. Credit: iStock

New research led by Northeastern University suggests that Alzheimer's disease may not progress like falling dominoes, as conventional wisdom holds, with one molecular event sparking the formation of plaques throughout the brain. Instead, it may progress like a fireworks display, with a unique flare launching each plaque, one by one.

The study, headed by Lee Makowski, professor and chair of the Department of Bioengineering, was published Thursday in the journal Scientific Reports.

"I believe the findings will provide us with a new way of thinking about the molecular basis for Alzheimer's ," says Makowski. "Once you do that, you can start asking the right questions about how to prevent it."

More than 5 million Americans are living with Alzheimer's disease, according to the Alzheimer's Association. It is the sixth leading cause of death in the U.S., the association reports, killing more people than breast and prostate cancers combined.

Yet much about its cause and the mechanisms driving its progression remain unknown. Alzheimer's disease typically starts with the death of brain cells, or "neurons," in one part of the brain and then, over time, slowly spreads to other regions. Amyloid fibrils—thin rigid strands of protein aggregates—accumulate in these areas of neuronal death, packing together to form dense plaques.

"Just as there are different strains of a virus, there appear to be different strains of fibrils," explains Makowski. "Remarkably, the different strains have the same chemical makeup but different three-dimensional structures."

Insight into therapies

It was the structures that Makowski's team zeroed in on.

In collaboration with researchers from Massachusetts General Hospital and Argonne National Laboratory's Advanced Photon Source, Makowski and former research associate Jiliang Liu, PhD'15, scanned slices of brain tissue retrieved at autopsy from four people with Alzheimer's and one with no history of dementia using an X-ray beam just five microns across. They then built images of the fibrous structures within the plaques from the thousands of diffraction patterns they collected.

Because fibrils self-propagate, researchers have speculated that all fibrils in a given brain are of the same strain and hence have the same structure. That led to the assumption that a single molecular event initiated their accumulation into plaques and the subsequent cascading progression of the disease.

"Our data wasn't consistent with that," says Makowski. "We found that fibrils with distinctly different structures can accumulate in the same brain, even in plaques quite close to one another. This strongly suggests that there is not one event that initiates fibril formation throughout the brain but many. Our research indicates that it is the condition under which fibrils form that slowly propagates through the brain and triggers a distinct initiation event for each plaque."

Think of a cold front traveling south from Massachusetts to Virginia. It's raining up and down the East Coast. When conditions are right in Massachusetts—that is, when the temperature drops to 32 degrees—the rain turns to snow (the initiation event). Virginia, however, doesn't get any snow until a week later when its temperature drops to the freezing point. As in the , the conditions drive the event.

"The findings are important because they change the way we think about disease progression," says Makowski. "It gives us a new point of view from which to develop hypotheses about the conditions that lead to the formation of fibrils and plaques."

The researchers also showed that the structure of the fibrils may vary based on a person's clinical history. For example, the fibrils of one woman who had exhibited no signs of dementia prior to death were distinctly different from those found in the others, who had Alzheimer's disease.

"This may mean that some strains of are associated with disease whereas others are not," says Makowski. "Distinguishing between them may provide critical insights for developing therapies to slow, halt, or reverse the neurodegeneration associated with Alzheimer's disease."

Explore further: Alzheimer's patients show striking individual differences in molecular basis of disease

Related Stories

Alzheimer's patients show striking individual differences in molecular basis of disease

September 12, 2013
Alzheimer's disease is thought to be caused by the buildup of abnormal, thread-like protein deposits in the brain, but little is known about the molecular structures of these so-called beta-amyloid fibrils. A study published ...

Alzheimer fibrils at atomic resolution

August 4, 2016
Elongated fibres (fibrils) of the beta-amyloid protein form the typical senile plaque present in the brains of patients with Alzheimer's disease. A European research team, working in conjunction with a team from the United ...

Recycling of Alzheimer's proteins could be key to new treatments

May 25, 2011
The formation of abnormal strands of protein called amyloid fibrils -- associated with two dozen diseases ranging from Alzheimer's to type-2 diabetes -- may not be permanent and irreversible as previously thought, scientists ...

Evidence for a remarkable structural diversity of amyloid fibrils in human and animal tissue

March 15, 2016
Formation of amyloid fibrils is a characteristic feature of neurogenerative diseases like Alzheimer's. As published in the journal Angewandte Chemie, German and American scientists have found evidence that these fibrils adopt ...

A molecular chain reaction in Alzheimer's disease

May 29, 2013
Researchers at Lund University in Sweden have identified the molecular mechanism behind the transformation of one of the components in Alzheimer's disease. They identified the crucial step leading to formations that kill ...

Recommended for you

Newly discovered biomarkers may lead to promising diagnostic tool for Alzheimer's

July 28, 2017
Diagnosing Alzheimer's disease and determining a patient's prognosis is an inexact business, and that stands in the way of better personalized care and advances in treatment.

BACE-Inhibitor successfully tested in Alzheimer's animal model

July 28, 2017
The protein amyloid beta is believed to be the major cause of Alzheimer's disease. Substances that reduce the production of amyloid beta, such as BACE inhibitors, are therefore promising candidates for new drug treatments. ...

Is it Alzheimer's or another dementia form? Why doctors need to distinguish

July 28, 2017
Alzheimer's disease now affects an estimated 5.5 million Americans, and after decades of feverish work, researchers have so far failed to find a treatment that halts or reverses the inexorable loss of memory, function and ...

Scientists use new data mining strategy to spot those at high Alzheimer's risk

July 28, 2017
The push to develop treatments for Alzheimer's disease has been a promising and disappointing endeavor over the past two decades, yielding a greater understanding of the disease yet still failing to generate successful new ...

Lifestyle changes to stave off Alzheimer's? Hints, no proof

July 20, 2017
There are no proven ways to stave off Alzheimer's, but a new report raises the prospect that avoiding nine key risks starting in childhood just might delay or even prevent about a third of dementia cases around the world.

Blood test identifies key Alzheimer's marker

July 19, 2017
A new study led by researchers at Washington University School of Medicine in St. Louis suggests that measures of amyloid beta in the blood have the potential to help identify people with altered levels of amyloid in their ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.